IL6 and breast carcinoma: Twenty fresh breast cancer tissue samples were collected to study the correlation between RNA levels of tumor-derived IL-6 and percentages of CD45+CD33+CD13+CD14−CD15− MDSCs in breast cancer tissues by flow cytometry analysis.